Provide total solutions for Life Science applications together with global partners. We are constantly striving to be more connected, forward-looking and customer-focused to deliver best results.
CRISPR-U™ has been successfully applied inmore than 100 types of cell lines. The high efficiency of this exclusive technology
can easily achieve knockout(KO), point mutation(PM), and knockin(KI), making Ubigene a industry-leading company
home and abroad.
Hurry up, take advantage of our best offer ever!
Limited Offers for 2020 : From July 1st to August 31th
We have been cooperated with noble clients from more than 20 countriesand 100 cities in Europe, Asia and North America.
Ubigene has alsoestablished offices in the United States, France and Hong Kong, which enablesour products to reach every
corner of the world.
CRISPR-U™ is an exclusive technologyindependently developed by Ubigene Bioscience for gene editing cell lines.
Byoptimizing gene editing vectors and processes, the efficiency in gene-cuttingand recombination of CRISPR-U™ is
10 times higher than the conventional CRISPR/Cas9 technology. CRISPR-U™ can easily achieve knockout(KO),
pointmutation(PM), and knockin(KI) in cell lines. Ubigene has been successfully appliedthis innovation in more than
100 types of cell lines. We are capable of customizing genetically-modified liver cell lines as you desireand satisfying
various needs in gene editing.